Focal Segmental Glomerulosclerosis clinical trials at UCSF

1 in progress, 0 open to eligible people

A Study to Evaluate PF-06730512 in Adults With Focal Segmental Glomerulosclerosis (FSGS)
Sorry, in progress, not accepting new patients
The purpose of this Phase 2 adaptive study is to evaluate the efficacy, safety, tolerability and pharmacokinetics of PF-06730512 following multiple intravenous infusions in adult subjects with FSGS.
San Francisco, California and other locations

Last updated: November 7, 2022